Ligand validation:7HIF

K34: 5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole

K34 is a Ligand Of Interest in 7HIF designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7HIF_K34_C_205	82%	1%	0.092	0.948	0.96	6.42	1	4	0	0	100%	0.56
7HID_K34_C_305	85%	1%	0.087	0.953	0.97	6.43	1	4	0	0	100%	0.57
7HIG_K34_C_303	77%	1%	0.098	0.936	0.95	6.33	1	4	0	0	100%	0.57
7H6K_K34_C_303	75%	14%	0.12	0.953	0.98	2.85	1	2	0	0	100%	0.68
7HIE_K34_C_202	72%	1%	0.111	0.935	0.96	6.34	1	4	0	0	100%	0.68
7HIC_K34_C_205	53%	1%	0.14	0.901	0.94	6.42	1	4	0	0	100%	0.56
5RLY_K34_B_702	86%	5%	0.114	0.984	0.89	4.35	-	2	0	0	100%	0.84

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.